Effect of rapid antiretroviral therapy initiation on loss to follow-up, mortality, and virologic failure among people with human immunodeficiency virus under the treat-all policy in China: analysis of routine data
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1736328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Juan Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Xi'an Eighth's Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: HIV Infections, Lost to Follow-Up, Anti-HIV Agents, Antiretroviral Therapy, Highly Active. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Since 2016, China has provided timely HIV antiretroviral therapy (ART) under the treat-all policy. This study aimed to evaluate the impact of rapid ART initiation (≤7 days post-HIV diagnosis) on loss to follow-up (LTFU), mortality, and virologic failure compared with that of delayed ART.
Methods
This study included adults with ART-naive HIV infection in Xi’an, China, between 2016 and 2022. Kaplan–Meier analysis was used to examine LTFU and death time for rapid and delayed ART initiation. Moreover, multivariate Cox regression was employed to evaluate the correlation between rapid ART initiation and LTFU/mortality, while logistic regression was utilized to assess the association between rapid ART and 12-month virologic failure.
Results
Of the 6992 participants, 770 (11.0%) initiated ART ≤7 days postdiagnosis. The percent of ART initiations in the first week postdiagnosis quadrupled from 4.2% in 2016 to 19.7% in 2022. The LTFU rate for rapid ART initiators was comparable to that in the 8–29- ( P = 0.132) and ≥30-day groups ( P = 0.432). Mortality was notably decreased in the rapid ART group (0.0%) than in the 8–29- (1.5%) and ≥30-day groups (2.2%). The rapid ART initiators demonstrated lower odds of developing virologic failure compared with delayed ART initiators (aOR: 0.50; 95% CI: 0.26–0.89; P = 0.028; ≤7 days versus ≥30 days).
Conclusions
Under China’s treat-all policy, rapid ART initiation showed equivalent LTFU but lower mortality and virologic failure. Chinese HIV patients may benefit from rapidly ART, but they require more intensive, tailored counseling to remain in treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Xi'an Eighth's Hospital, Xi'an, Shaanxi, China.
- Department of Infectious Diseases, Infectious Disease Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
Zitieren
APA
Jin, J., Pan, S., Jing, X., Ba, H., Zhang, Y., Li, J., Yin, J., Luo, P., Hou, H., & Ma, K. (2026). Effect of rapid antiretroviral therapy initiation on loss to follow-up, mortality, and virologic failure among people with human immunodeficiency virus under the treat-all policy in China: analysis of routine data. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1736328
Vancouver
Jin J, Pan S, Jing X, Ba H, Zhang Y, Li J, et al. Effect of rapid antiretroviral therapy initiation on loss to follow-up, mortality, and virologic failure among people with human immunodeficiency virus under the treat-all policy in China: analysis of routine data. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1736328
BibTeX
@article{Jin2026,
author = {Jin, Juan and Pan, Songnan and Jing, Xinyan and Ba, Huanhuan and Zhang, Yuan and Li, Jiajia and Yin, Jinling and Luo, Peipei and Hou, Haohua and Ma, Kangxiao},
title = {Effect of rapid antiretroviral therapy initiation on loss to follow-up, mortality, and virologic failure among people with human immunodeficiency virus under the treat-all policy in China: analysis of routine data},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1736328}
}
EUVIMED